Replies to post #1417 on RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

Re: Timing of a non-Ampakine inlicensing: I'm betting on Jan-February.

---

Do you see that as being before, after, or as part of the BP licensing deal?

And do you think it more or less likely that the in-licensed drug will come from the BP partner?

Thanks... Aiming4.

[bladerunner1717]

Neuro,

Can you give us some insight into this Thomas Laughren guy? Does he have much of a track record from which to glean anything about his predilections?


Bladerunner